P WAVE | PR INTERVAL | QRS WAVE | QT INTERVAL | ST SEGMENT | T WAVE | U WAVE | |
HYPOKALEMIA | prolonged PR | depressed ST | flat or inverted T | prominent U | |||
HYPERKALEMIA | absent P | prolonged PR | wide QRS | prolonged QT | depressed ST | tall T | |
HYPOCALCEMIA | prolonged QT | lengthened ST | |||||
HYPERCALCEMIA | shortened QT | ||||||
HYPOMAGNESEMIA | prolonged PR | prolonged QT | depressed ST | flat or inverted T | |||
HYPERMAGNESEMIA | prolonged PR | wide QRS | |||||
CLASSICAL MI | pathologic Q (zone of infarction) | elevated ST (zone of injury) | inverted T (zone of ischemia) | ||||
ANGINA PECTORIS | depressed ST | peaked or flat or inverted T | |||||
PERICARDITIS | elevated ST | peaked T |
Wednesday, July 20, 2011
ECG ABNORMALITIES
COMMON CHEMOTHERAPY DRUGS
DRUG | CLASS | TARGET | ORGAN TOXICITY | OTHER SIDE EFFECTS | INTERVENTIONS |
CELL CYCLE SPECIFIC | |||||
methotrexate | ANTIMETABOLITE | folic acid, pyrimidine, purine | hepatotoxic nephrotoxic | photosensitivity acute tumor lysis syndrome | administer leucovorin to stop cell lysis administer allopurinol for uric acid from cell lysis |
fluorouracil | cardiotoxic | ||||
vincristine | VINCA ALKALOID | M phase | neurotoxic | peripheral neuropathy (esp. foot drop) hyponatremia constipation | increase fluid intake adequate sodium diet prevent foot drop |
paclitaxel | TAXANE | M phase | none | anaphylaxis | skin test premedicate with steroids, antihistamines, H2 blockers |
irinotecan AND topotecan | TOPOISOMERASE I INHIBITOR | S phase | none | severe diarrhea | administer loperamide OR atropine for severe diarrhea |
etoposide | TOPOISOMERASE II INHIBITOR | none | hypotension | monitor BP closely | |
NON-CELL CYCLE SPECIFIC | |||||
cyclophosphamide | ALKYLATING AGENTS | DNA structure | nephrotoxic | hemorrhagic cystitis sterility | administer early in the morning increase oral fluid intake assess urine for blood void frequently especially before bed |
cisplatin | nephrotoxic ototoxic | highly emetogenic peripheral neuropathy Mg & K imbalances | administer 5-HT3 antagonists for emesis monitor I/O, creatinine, and BUN increase oral fluid intake administer mannitol | ||
doxorubicin | ANTIBIOTICS | cardiotoxic | red-colored urine HepB reactivation | monitor ECG and echocardiograms | |
bleomycin | pulmotoxic | anaphylaxis | skin test assess lung sounds from time to time | ||
tamoxifen | ANTIESTROGEN | estrogen receptors | hepatotoxic | deep vein thrombosis decreased libido steatorrhea | monitor liver enzymes decreased fat intake |
asparaginase | OTHERS | amino acid asparagine | pancreatitis | anaphylaxis | skin test |
hydroxyurea | DNA and RNA structure | hepatotoxic nephrotoxic | acute myeloid leukemia | monitor I/O, creatinine, and BUN, liver enzymes |
COMMON TUMOR MARKERS | |
alpha fetoprotein (AFP) - liver cancer bladder tumor antigen (BTA) - bladder cancer CA 15-3 - breast cancer CA 125 - ovarian cancer calcitonin - thyroid cancer | carcinoembryonic antigen (CEA) - colon cancer estrogen/progesterone receptors - breast cancer human chorionic gonadotropin (HCG) - choriocarcinoma prostate specific antigen - prostate cancer |
NORMAL VALUES
LAB / DIAGNOSTIC TEST | NORMAL VALUE | ||
ARTERIAL BLOOD GASES | |||
pH | 7.35-7.45 | ||
HCO3 | 22-26 mmol/L | ||
PCO2 | 35-45 mmHg | ||
PO2 | 75-100 mmHg | ||
SO2 / O2SAT | 96-100% | ||
BLOOD CHEMISTRY | |||
Albumin | 3.5-5.0 g/dL | ||
Glucose | 80-120 mg/dL | ||
SERUM ELECTROLYTES | |||
K | 3.5-5.0 mEq/L | ||
Na | 135-145 mEq/L | ||
Ca | 8.5-10.5 mg/dL | ||
Mg | 1.5-2.0 mEq/L | ||
Cl | 100-106 mEq/L | ||
HEMATOLOGY | |||
RBC | M | 4.6-6.2 M/cu mm | |
F | 4.2-5.9 M/cu mm | ||
RBC Lifespan | 80-120 days | ||
Hematocrit | M | 45-52% | |
F | 37-48% | ||
Hemoglobin | M | 13-18 g/dL | |
F | 1-16 g/dL | ||
WBC | 4,000-10,000/cu mm | ||
Platelet | 150,000-300,000/cu mm | ||
COAGULATION TESTS | |||
PT ***warfarin*** | 10-12 sec | ||
APTT ***heparin*** | 21-35 sec | ||
Bleeding Time | 3-7 min | ||
LIVER FUNCTION TESTS | |||
SGOT / AST | M | 15-40 U/L | |
F | 13-35 U/L | ||
SGPT / ALT | M | 10-40 U/L | |
F | 7-35 U/L | ||
Total Bilirubin | 0.3-1.2 mg/dL | ||
KIDNEY FUNCTION TESTS | |||
Urine Output | 30-60 cc/hr | ||
BUN | 6-23 mg/Dl | ||
Creatinine | 15-25 mg/kg of body weight/day | ||
Uric Acid | M | 4.0-9.0 mg/dL | |
F | 3.0-6.5 mg/dL | ||
METABOLIC WASTES | |||
Ammonia | 12-55 μmol/L | ||
Lactic Acid | 0.6-1.8 mEq/L | ||
Uric Acid | 3.0-7.0 mg/dL | ||
LIPID PANEL | |||
Total Cholesterol | < 200 mg/dL | ||
HDL | 30-75 mg/dL | ||
LDL | < 130 mg/dL | ||
Triglycerides | 40-150 mg/dL | ||
CARDIAC MARKERS | |||
CPK-MB | 0-5 ng/mL | ||
Troponin I | 0-0.1 ng/mL | ||
HEMODYNAMICS | |||
Mean Arterial Pressure | 70-90 mmHg | ||
Pulse Pressure | 30-40 mmHg | ||
Cardiac Output | 4-8 L/min | ||
Central Venous Pressure | 2-6 mmHg | ||
Pulmonary Artery Wedge Pressure | 10-15 mmHg | ||
Pulmonary Capillary Wedge Pressure | 4-12 mmHg | ||
ELECTROPHYSIOLOGY | |||
SA Node Firing Rate | 60-100 bpm | ||
AV Node Firing Rate | 40-60 bpm | ||
THERAPEUTIC VALUES | |||
Digoxin | 0.5-2.0 μg/L | ||
Lithium | 0.6-1.2 mEq/L | ||
Phenytoin | 10-20 μg/mL | ||
DISEASE MARKERS | |||
CA 125 ***cancer*** | < 35 U/mL | ||
AFP ***hepatocarcinoma*** | 200-400 mg/dL | ||
VMA (Vanillylmandelic Acid) ***pheochromocytoma*** | 1.4-6.5mg/24hr | ||
Prostate Specific Antigen ***prostate cancer*** | <4 ng/mL | ||
ESR ***inflammation*** | 0-15 mm/hr | ||
C-Reactive Protein (CRP) ***inflammation*** | 0-4.9 mg/L | ||
Rheumatoid Factor ***rheumatoid arthritis*** | 0-20 IU/mL | ||
Blood Alcohol Level | <0.03 | ||
PEDIATRIC RESPIRATORY FUNCTION | |||
L:S Ratio | 2:1 | ||
BLOOD LOSS | |||
NSVD | 500cc | ||
CS | 1000cc | ||
Monthly Menses | ¼ cup or 30-50 cc | ||
MUCOSAL PH | |||
Vagina | 4.5-5.5 | ||
Stomach | < 4.0 | ||
OPTOMETRY | |||
IOP | 10-21 mmHg | ||
Normal Vision | 20/20 | ||
Legally Blind | 200/20 | ||
CEREBROSPINAL FLUID | |||
ICP | 4-10 mmHg | ||
CSF Amount | 150 mL | ||
CSF Pressure | 75-150 mmH2O | ||
PHYSICAL ASSESSMENT | |||
CRT | 2-3 sec | ||
Bowel Sounds | 5-35 per minute | ||
Rinne Test | AC > BC | ||
Webber Test | BC > AC | ||
# of Permanent Teeth | 32 | ||
# of Ribs | 12 pairs | ||
# of Vertebrae | Cervical | 8 | |
Thoracic | 12 | ||
Lumbar | 5 | ||
Sacral | 5 | ||
Coccyx | 1 | ||
# of Bones | Child | 260 | |
Adult | 206 | ||
# of Muscles | 620 | ||
REPRODUCTIVE | |||
Ejaculation Volume | 3-5 mL | ||
Sperm Count | 20-200 M/mL | ||
SPECIFIC DIAGNOSTICS | |||
Tourniquet | <20 petechiae / sq inch | ||
Mantoux | <10mm in 48-72 hrs | ||
Sweat Chloride | <60 mEq/L | ||
LABOR & DELIVERY | |||
Lochia | Rubra | 1-3 days | |
Serosa | 4-7 days | ||
Alba | 8-10 days | ||
Term Labor | 37-42 weeks | ||
Age of Viability | 20 weeks | ||
Amniotic Fluid | 800-1,200 mL | ||
Cervical Dilation | Latent | 0-3 cm | |
Active | 4-7 cm | ||
Transition | 8-10 cm | ||
Head Circumference | 34-35 cm | ||
Chest Circumference | 32-33 cm | ||
Length | 46-54 cm | ||
Weight | 2.5-3.4 kg | ||
MIXTURES | |||
ORESOL | 1L H2O: 1tsp salt : 8 tsp sugar | ||
Benedict’s Test | 5mL Benedict’s + 8-10 drops urine | ||
Saline Solution | 1 L H2O + 2 tsp salt | ||
Paraffin Wax | 7:1 (wax : mineral oil) | ||
PREGNANCY WEIGHT GAIN | |||
1st Trimester | 1 lb/mo | ||
2nd Trimester | 1 lb/wk | ||
3rd Trimester | 1 lb/wk | ||
STAFFING | |||
AM Shift | 45% | ||
PM Shift | 37% | ||
Night Shift | 18% | ||
RESEARCH | |||
Null Hypothesis Alpha | 0.05 | ||
SPECIMEN | AMOUNT TO COLLECT | |
Sputum | 15-30 mL | |
Semen | 3-5 mL | |
Stool | Formed | 1 inch |
Liquid | 15 mL | |
Urine | Clean | 15-30 mL |
Sterile | 5 mL | |
Centesis | 3-5 mL |
AGE GROUP | NORMAL RANGE |
PULSE RATE | |
Newborn | 100-170 bpm |
1 yr | 80-170 bpm |
3 yr | 80-130 bpm |
6 yr | 75-120 bpm |
Adult | 60-100 bpm |
RESPIRATORY RATE | |
Newborn | 30-50 bpm |
1 yr | 20-40 bpm |
3 yr | 20-30 bpm |
6 yr | 16-22 bpm |
Adult | 12-20 bpm |
BLOOD PRESSURE | |
Newborn | 65-95/30-60 |
1 yr | 65-115/40-80 |
3 yr | 75-120/45-85 |
6 yr | 85-115/50-65 |
Adult | 90-120/60-80 |
SOURCES:
Davis' Comprehensive Handbook of Laboratory and Diagnostic Tests
Maternal and Child Health Nursing by A. Pilliteri
Mosby's PDQ for Nursing
and other various source...
Davis' Comprehensive Handbook of Laboratory and Diagnostic Tests
Maternal and Child Health Nursing by A. Pilliteri
Mosby's PDQ for Nursing
and other various source...
Subscribe to:
Posts (Atom)